BROOKLYN CENTER, Minn. — Medtronic is giving a group of international VIPs a rare, behind the scenes tour of its operations ...

Medtronic's MiniMed Group filed for a U.S. initial public offering on Friday, as the medical device maker moves ahead with ...

Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its ...

Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

The company received three complaints about patients who had perforation injuries linked to the devices.

Earlier this month, Medtronic said the FDA granted the indication for its Onyx liquid embolic system (LES) in the U.S. Onyx ...

Explore MiniMed Group, Inc.'s upcoming IPO, market position in diabetes devices, and key financial risks. Click for this MMED ...

With the Own It effort, Medtronic is providing a way for those living with diabetes to celebrate ordinary moments made possible with the right technology so they can own every choice.

December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. Valued at $134.7 billion by ...